Team
health

SAPS II Calculator

The SAPS II score quantifies illness severity in intensive care patients aged 15 and older by integrating vital signs, laboratory values, and admission type. Clinicians use this 15-variable scoring system to predict in-hospital mortality risk and guide resource allocation. Developed from a 1991 multinational study of nearly 13,000 ICU admissions, SAPS II remains a standard prognostication method in critical care, though it should complement rather than replace clinical judgment.

Last updated:

Creators Małgorzata Koperska, MD
310 people find this calculator helpful

Understanding SAPS II Scoring

SAPS II combines physiological measurements captured within the first 24 hours of ICU admission with chronic disease history and admission circumstances. The score aggregates points across 15 distinct variables, each contributing a weighted severity assessment. Higher scores correlate with increased mortality risk through a non-linear sigmoid relationship.

The tool captures:

  • Vital parameters: age, heart rate, systolic blood pressure, core temperature
  • Neurological status: Glasgow Coma Score (lowest value in 24 hours)
  • Respiratory function: arterial oxygen pressure (PaO₂) and inspired oxygen concentration (FiO₂)
  • Renal output: 24-hour urine volume
  • Biochemistry: sodium, potassium, bicarbonate, bilirubin, white blood cell count, and nitrogen metabolism (BUN or serum urea)
  • Chronic conditions: AIDS, haematologic malignancy, or metastatic cancer
  • Admission type: medical, scheduled surgical, or emergent surgical

Each variable awards points based on deviation from normal ranges. The summated score generates a mortality probability through logistic regression, reflecting population-level risk stratification rather than individual outcome prediction.

SAPS II Mortality Calculation

The score aggregates points from vital signs, laboratory abnormalities, organ dysfunction, and admission context. Four mortality estimates derive from combinations of respiratory and renal data availability:

SAPS points = age + heart rate + systolic BP + temperature + GCS

+ urine output + sodium + potassium + bicarbonate

+ bilirubin + WBC + (PaO₂/FiO₂ if measured)

+ (BUN or serum urea) + cancer severity + admission type

Logit = 0.0737 × SAPS points + 0.9971 × ln(SAPS points) − 7.7631

Mortality (%) = [e^logit / (1 + e^logit)] × 100

  • SAPS points — Sum of all 15 variable scores; ranges from 0 to ~160+
  • PaO₂/FiO₂ — Arterial oxygen pressure divided by fractional inspired oxygen; included if measured within 24 hours
  • Logit — Linear predictor from logistic regression model calibrated on 1991 cohort
  • Mortality (%) — Predicted in-hospital mortality probability

Interpreting SAPS II Results and Mortality Risk

Mortality risk exhibits a sigmoid dose–response relationship with increasing SAPS II scores. Below are approximate clinical reference points from the original 1991 derivation cohort:

  • 25–30 points: ~10% predicted mortality — predominantly physiologically stable patients with reversible acute illness
  • 40 points: ~25% predicted mortality — moderate organ dysfunction
  • 52 points: ~50% predicted mortality — substantial multi-organ involvement
  • 64 points: ~75% predicted mortality — severe, life-threatening derangements
  • 77+ points: ~90% predicted mortality — profound physiological derangement

Individual risk stratification depends on whether blood gas and renal biochemistry data are available. Four variants exist: with or without arterial blood gas, with or without renal function labs. Missing data should not be imputed; use whichever risk model matches available measurements.

Population and Applicability Scope

SAPS II was validated in a 1991 cohort spanning 12,997 patients admitted to ICUs across 12 countries. The tool applies to patients aged 15 years and older. Notably, the original derivation excluded patients with acute thermal burn injuries and primary cardiac diagnoses requiring coronary intervention, so SAPS II performance may not generalise reliably to these populations.

The score should be calculated once per ICU admission using the physiological values that score the most points during the first 24 hours. If a patient is discharged and subsequently readmitted to the ICU, a new SAPS II assessment is appropriate. SAPS II is designed for prognostication at or shortly after ICU admission and should not guide treatment decisions in isolation from clinical evaluation, imaging, and organ-support requirements.

Critical Caveats and Practical Considerations

Several important limitations and usage pitfalls should inform SAPS II interpretation and application.

  1. Use highest/lowest values appropriately — SAPS II scoring requires the value from the past 24 hours that contributes the most points—not necessarily the numerically extreme value. For instance, if a patient had sodium fluctuations of 125 and 155 mEq/L, select whichever awards more points. Similarly, use the lowest GCS within 24 hours but before sedative administration if the patient was later sedated for mechanical ventilation.
  2. Account for missing data and model variants — Four risk predictions emerge depending on whether arterial blood gas and renal chemistry are measured. Do not impute missing values. If PaO₂/FiO₂ is unavailable, use the non-respiratory model. If BUN or serum urea is missing, recalculate without that component. Reporting should specify which SAPS variant was employed.
  3. Recognise temporal and population drift — SAPS II was derived 30+ years ago from patients in specific healthcare systems. Contemporary ICU populations differ in age distribution, comorbidity, antimicrobial access, and supportive care standards. Calibration to your own institution may reveal systematic over- or underestimation of mortality. Use SAPS II as a comparative risk tool within your cohort rather than as an absolute forecast.
  4. Exclude ineligible diagnoses and document assumptions — Patients with acute burns or those admitted primarily for coronary revascularisation fall outside the derivation cohort. If SAPS II is applied to these groups, results should be interpreted with caution. Always document the timing of measurements, whether sedation was employed, and any clinical caveats that might limit generalisability of the predicted risk.

Frequently Asked Questions

What is the difference between SAPS II and APACHE II scoring?

APACHE II and SAPS II are both severity-of-illness scores used in intensive care, but they differ in scope and patient applicability. APACHE II includes chronic health status and is designed for newly admitted ICU patients (not internal transfers) and excludes those with liver failure or HIV. SAPS II focuses purely on acute physiological derangement during the first 24 hours and applies more broadly to all ICU admissions aged 15+, including transfers. APACHE II requires 34 variables compared to SAPS II's 15, making SAPS II faster to calculate. Both yield comparable prognostication accuracy across diverse ICU populations.

Why use SAPS II instead of simpler vital sign assessment?

Vital signs alone miss the cumulative burden of multi-organ dysfunction. SAPS II integrates laboratory abnormalities (electrolytes, kidney and liver function, inflammation markers) and neurological status (GCS) alongside vitals, creating a composite severity portrait. A patient with a normal heart rate but severe hypoxia and hyperkalaemia would be risk-stratified differently than one with tachycardia and normal labs. This granular approach improves prognostic discrimination and identifies patients who need more aggressive critical care resource allocation.

Can SAPS II predict individual patient outcomes?

No. SAPS II is a population-level risk tool; it predicts average mortality probability for cohorts of patients with similar scores, not individual trajectories. Two patients with identical SAPS II scores may have vastly different clinical courses due to unmeasured factors (frailty, functional reserve, late-life complications, treatment decisions). The model should inform prognostic conversations with families and clinicians but must never replace individualised clinical judgment, organ support goals, or shared decision-making about treatment escalation.

How should I handle missing data when calculating SAPS II?

Do not impute missing measurements. Instead, use the SAPS II variant that matches your available data. If arterial blood gas (PaO₂/FiO₂) is unavailable, calculate the non-respiratory SAPS score. If renal biochemistry (BUN or urea) is missing, omit that component. Most ICU patients will have vitals, GCS, routine labs, and urine output within 24 hours, permitting at least one valid SAPS II estimate. Report which variant was used so downstream clinicians understand the scope of assessment.

When should SAPS II be recalculated during an ICU stay?

SAPS II is typically calculated once at or within 24 hours of ICU admission. Recalculation is not routinely recommended for monitoring trends because the score was designed as a point-in-time severity snapshot for prognostication. However, if a patient is discharged from the ICU and then readmitted (a new ICU stay), a fresh SAPS II score is appropriate. Some centres recalculate after major interventions or clinical deterioration for quality improvement audits, but this is outside the original validation scope.

Are there limitations to SAPS II in modern intensive care?

Yes. SAPS II was derived in 1991; modern ICUs now employ advanced organ support (ECMO, renal replacement, high-frequency oscillation) and antimicrobials unavailable then. Survival for equivalent severity has improved substantially. The score may overestimate mortality in contemporary cohorts, particularly in resource-rich healthcare systems. Additionally, SAPS II was validated in specific international centres and may require local calibration. Finally, it does not account for patient age as a prognostic modifier independent of acute physiology, which influences real-world decision-making in older patients with comorbidities.

More health calculators (see all)

Standard Drink Calculator Positive Pregnancy Test Calculator VLDL Calculator BMR Katch-McArdle Calculator Bladder Volume Calculator A Body Shape Index (ABSI) Calculator VBAC Risk Score Calculator Cardiac Index Calculator